Literature DB >> 1346575

2-Chlorodeoxyadenosine treatment of lymphoid malignancies.

L D Piro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1346575

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.

Authors:  Tieran Han; Marilyn Fernandez; Ting-Chao Chou; Ram P Agarwal
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

2.  2-Chloro-2' deoxyadenosine prevents angiopathic changes in cerebral arteries in experimental SAH in rabbits.

Authors:  M Ryba; P Grieb; M Walski; J Sawicki; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 3.  Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 4.  Clinical and toxicological aspects of the antineoplastic drug cladribine: a review.

Authors:  H J Guchelaar; D J Richel; M R Schaafsma
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673

Review 5.  Cytokines in the pathophysiology and treatment of chronic B-cell malignancies. A review.

Authors:  M Schuler; C Huber; C Peschel
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

6.  Genomic structure and chromosomal localization of the human deoxycytidine kinase gene.

Authors:  J J Song; S Walker; E Chen; E E Johnson; J Spychala; T Gribbin; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 7.  Treatment options--commentary.

Authors:  R J Arceci
Journal:  Br J Cancer Suppl       Date:  1994-09

8.  Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine.

Authors:  M Ryba; P Grieb; M Pastuszko; J Bidziński; J Andrychowski; C Dziewiecki; P Bojarski; L Królicki
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

9.  2-Chlorodeoxyadenosine treatment for cutaneous T-cell lymphoma.

Authors:  Małgorzata Sokołowska-Wojdyło; Magdalena Trzeciak; Jadwiga Roszkiewicz
Journal:  Dermatol Reports       Date:  2010-09-02

10.  2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies.

Authors:  T Hickish; P Serafinowski; D Cunningham; A Oza; E Dorland; I Judson; B C Millar; T A Lister; A Roldan
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.